Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease.
Haberman RH, Um S, Axelrad JE, Blank RB, Uddin Z, Catron S, Neimann AL, Mulligan MJ, Herat RS, Hong SJ, Chang S, Myrtaj A, Ghiasian G, Izmirly PM, Saxena A, Solomon G, Azar N, Samuels J, Golden BD, Rackoff P, Adhikari S, Hudesman DP, Scher JU; SAGA investigators. Haberman RH, et al. Among authors: mulligan mj. Lancet Rheumatol. 2022 Jun;4(6):e384-e387. doi: 10.1016/S2665-9913(22)00069-8. Epub 2022 Apr 1. Lancet Rheumatol. 2022. PMID: 35403000 Free PMC article. No abstract available.
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease.
Haberman RH, Herati R, Simon D, Samanovic M, Blank RB, Tuen M, Koralov SB, Atreya R, Tascilar K, Allen JR, Castillo R, Cornelius AR, Rackoff P, Solomon G, Adhikari S, Azar N, Rosenthal P, Izmirly P, Samuels J, Golden B, Reddy SM, Neurath MF, Abramson SB, Schett G, Mulligan MJ, Scher JU. Haberman RH, et al. Among authors: mulligan mj. Ann Rheum Dis. 2021 Oct;80(10):1339-1344. doi: 10.1136/annrheumdis-2021-220597. Epub 2021 May 25. Ann Rheum Dis. 2021. PMID: 34035003 Free PMC article.
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
Izmirly PM, Kim MY, Samanovic M, Fernandez-Ruiz R, Ohana S, Deonaraine KK, Engel AJ, Masson M, Xie X, Cornelius AR, Herati RS, Haberman RH, Scher JU, Guttmann A, Blank RB, Plotz B, Haj-Ali M, Banbury B, Stream S, Hasan G, Ho G, Rackoff P, Blazer AD, Tseng CE, Belmont HM, Saxena A, Mulligan MJ, Clancy RM, Buyon JP. Izmirly PM, et al. Among authors: mulligan mj. Arthritis Rheumatol. 2022 Feb;74(2):284-294. doi: 10.1002/art.41937. Epub 2021 Dec 28. Arthritis Rheumatol. 2022. PMID: 34347939 Free PMC article.
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis.
Blank RB, Haberman RH, Qian K, Samanovic M, Castillo R, Jimenez Hernandez A, Vasudevapillai Girija P, Catron S, Uddin Z, Rackoff P, Solomon G, Azar N, Rosenthal P, Izmirly P, Samuels J, Golden B, Reddy S, Mulligan MJ, Hu J, Scher JU. Blank RB, et al. Among authors: mulligan mj. Rheumatology (Oxford). 2022 Dec 23;62(1):467-472. doi: 10.1093/rheumatology/keac322. Rheumatology (Oxford). 2022. PMID: 35640110 Free PMC article.
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19.
Chen P, Datta G, Grace Li Y, Chien J, Price K, Chigutsa E, Brown-Augsburger P, Poorbaugh J, Fill J, Benschop RJ, Rouphael N, Kay A, Mulligan MJ, Saxena A, Fischer WA, Dougan M, Klekotka P, Nirula A, Benson C. Chen P, et al. Among authors: mulligan mj. Clin Pharmacol Ther. 2021 Dec;110(6):1467-1477. doi: 10.1002/cpt.2405. Epub 2021 Oct 16. Clin Pharmacol Ther. 2021. PMID: 34455583 Free PMC article. Clinical Trial.
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Şahin U, Gruber WC. Walsh EE, et al. Among authors: mulligan mj. N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14. N Engl J Med. 2020. PMID: 33053279 Free PMC article. Clinical Trial.
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients.
Ulrich RJ, Troxel AB, Carmody E, Eapen J, Bäcker M, DeHovitz JA, Prasad PJ, Li Y, Delgado C, Jrada M, Robbins GA, Henderson B, Hrycko A, Delpachitra D, Raabe V, Austrian JS, Dubrovskaya Y, Mulligan MJ. Ulrich RJ, et al. Among authors: mulligan mj. Open Forum Infect Dis. 2020 Sep 23;7(10):ofaa446. doi: 10.1093/ofid/ofaa446. eCollection 2020 Oct. Open Forum Infect Dis. 2020. PMID: 33134417 Free PMC article.
Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisation.
Salerno-Gonçalves R, Chen WH, Mulligan MJ, Frey SE, Stapleton JT, Keitel WA, Bailey J, Sendra E, Hill H, Johnson RA, Sztein MB. Salerno-Gonçalves R, et al. Among authors: mulligan mj. Clin Transl Immunology. 2021 Jan 19;10(1):e1239. doi: 10.1002/cti2.1239. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33505681 Free PMC article.
252 results